By Admin at 14 Mar 2017

The usual treatment for metastatic colorectal cancer includes chemotherapy, radiation and surgical resection. Unfortunately, the average survival rate has been only 20-24 months. In a Gateway-funded clinical trial led by Dr. Edward Lin, a survival rate of approximately 94+ months was achieved using a new approach called ADAPT – Activate tumor from Dormancy And Potentiate its Targeting.